CAPPED BONUSZERTIFIKAT - STRYKER CORP. Share Price

Certificat

DE000PC5RT36

Market Closed - Boerse Frankfurt Warrants 01:10:26 29/06/2024 am IST
289.6 EUR -0.04% Intraday chart for CAPPED BONUSZERTIFIKAT - STRYKER CORP.
Current month+1.68%
1 month+1.85%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/24/28 289.3 -0.17%
27/24/27 289.8 -0.29%
26/24/26 290.6 +0.33%
25/24/25 289.6 +0.33%
24/24/24 288.7 -0.33%

Real-time Boerse Frankfurt Warrants

Last update June 29, 2024 at 01:10 am IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5RT3
ISINDE000PC5RT36
Date issued 27/02/2024
Strike 320 $
Maturity 20/12/2024 (173 Days)
Parity 1 : 1
Emission price 277.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 290.9
Lowest since issue 276.1
Spread 0.5
Spread %0.17%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.2 USD
Average target price
372.9 USD
Spread / Average Target
+9.61%
Consensus